Yesterday, the EVP of Translational Sciences and Chief Quality Of of Ultragenyx Pharmaceutical (RARE – Research Report), John Richard Pinion,
Category: Insider Trades
News of the most recent top company executives directors and major shareholders’ buy and sell trades of their shares in the company.
This section covers only the most meaningful transactions by the insiders, which may be an indication of the insider beliefs in the company. Any scheduled transactions or an executive liquidating their corporate stock, will not be covered here as they do not relate to any events going on at the company.
The EVP & Chief Tech Ops Officer of Ultragenyx Pharmaceutical (NASDAQ: RARE) is Selling Shares
Yesterday, the EVP & Chief Tech Ops Officer of Ultragenyx Pharmaceutical (RARE – Research Report), Dennis Karl Huang, sold shares
The Chairman, President & Chief Executive Officer of JPMorgan Chase & Co. is Exercising Options
Yesterday it was reported that the Chairman, President & Chief Executive Officer of JPMorgan Chase & Co. (JPM – Research
The Chief Customer Officer of Allscripts (NASDAQ: MDRX) is Selling Shares
Yesterday, the Chief Customer Officer of Allscripts (MDRX – Research Report), Lisa Khorey, sold shares of MDRX for $165.6K. Following
A Director at Citigroup (NYSE: C) is Selling Shares
Yesterday, a Director at Citigroup (C – Research Report), Gary Reiner, sold shares of C for $49.83K. This is Reiner’s
The Non-Executive of Cabral Gold is Exercising Options
Today it was reported that the Non-Executive of Cabral Gold (CBGZF – Research Report), Derrick Horst Weyrauch, exercised options to
The Chief Executive Officer of BIGG Digital Assets (Other OTC: BBKCF) is Buying Shares
Today, the Chief Executive Officer of BIGG Digital Assets (BBKCF – Research Report), Lance Morginn, bought shares of BBKCF for